Cargando…

Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I–III patients with colorectal cancer after operation

INTRODUCTION: Chemokines are closely related with tumor immunity, progression, and metastasis. We aimed to construct a multi-RNA classifier of chemokine family genes for predicting tumor recurrence in stage I–III patients with colorectal cancer (CRC) after operation. PATIENTS AND METHODS: By analyzi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Guozeng, Zhou, Yuehan, Zhou, Fuxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173492/ https://www.ncbi.nlm.nih.gov/pubmed/30323661 http://dx.doi.org/10.2147/CMAR.S174452

Ejemplares similares

Two tripartite classification systems of CD86(+) and CD206(+) macrophages are significantly associated with tumor recurrence in stage II-III colorectal cancer
por: Xu, Guozeng, et al.
Publicado: (2023)

The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer
por: Xu, Guozeng, et al.
Publicado: (2021)

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer
por: Feng, Junlan, et al.
Publicado: (2021)

High Infiltration of CD203c(+) Mast Cells Reflects Immunosuppression and Hinders Prognostic Benefit in Stage II-III Colorectal Cancer
por: Li, Jing, et al.
Publicado: (2023)

Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study
por: Nors, Jesper, et al.
Publicado: (2023)

Peritoneal recurrence after resection for Stage I–III colorectal cancer: A population analysis
por: Aiken, Taylor, et al.
Publicado: (2022)

Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern
por: Sawayama, Hiroshi, et al.
Publicado: (2021)

Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
por: Gao, Zhaoya, et al.
Publicado: (2023)

The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
por: Oladipo, O, et al.
Publicado: (2011)

Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III
por: Belt, E. J. Th., et al.
Publicado: (2010)

Frailty is an independent risk factor for recurrence and mortality following curative resection of stage I–III colorectal cancer
por: Mima, Kosuke, et al.
Publicado: (2020)

Role of Chronic Inflammatory Ratios in Predicting Recurrence of Resected Patients with Stage I–III Mucinous Colorectal Adenocarcinoma
por: Liao, Yu-Cui, et al.
Publicado: (2021)

Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer
por: Cavalleri, Tommaso, et al.
Publicado: (2022)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Clinical significance of carcinoembryonic antigen in peritoneal fluid detected during operation in stage I–III colorectal cancer patients
por: Kim, Jae Hyun, et al.
Publicado: (2018)

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
por: Liang, Cuishan, et al.
Publicado: (2016)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
por: Posch, Florian, et al.
Publicado: (2017)

An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Liang, Yushan, et al.
Publicado: (2019)

Risk factors of recurrence in TNM stage I colorectal cancer
por: Paik, Jin-Hee, et al.
Publicado: (2023)

Pre- and post-diagnostic dairy intake in relation to recurrence and all-cause mortality in people with stage I-III colorectal cancer
por: van Lanen, Anne-Sophie, et al.
Publicado: (2023)

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III
por: Jiang, Minlin, et al.
Publicado: (2021)

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Report of Sixty-Nine Cataract Operations
por: Calhoun, A. W.
Publicado: (1876)

Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2022)

The Glasgow Microenvironment Score and risk and site of recurrence in TNM I–III colorectal cancer
por: Alexander, P. G., et al.
Publicado: (2022)

Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
por: Peng, Jianhong, et al.
Publicado: (2020)

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2019)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Mueller matrix polarization parameters correlate with local recurrence in patients with stage III colorectal cancer
por: Tumanova, Kseniia, et al.
Publicado: (2023)

Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients
por: Zhou, Ting, et al.
Publicado: (2018)

Development and validation of an individualized immune prognostic model in stage I–III lung squamous cell carcinoma
por: Yang, Qi-Fan, et al.
Publicado: (2021)

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer
por: Yu, Tong, et al.
Publicado: (2021)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer
por: Li, Xiangde, et al.
Publicado: (2019)

Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic
por: Ahlborn, Lise B., et al.
Publicado: (2015)

A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer
por: Cai, Zhiqiang, et al.
Publicado: (2022)

Nine papers on number theory and operator theory
por: Brodskii, M S
Publicado: (1960)

Cannot write session to /tmp/vufind_sessions/sess_33la4v62rr4et7tj0uudqkmt54